NOTV Inotiv Corporation: Net earnings per share for the last four quarters

Public company logo of Inotiv Corp (NOTV)

Inotiv, Inc. (NOTV) specializes in preclinical outsourcing, facing pressure from debt and potential spending cuts by biopharmaceutical companies on research and development. This chart of the market price on GURU.Markets reflects an EPS of 20.40. Inotiv, Inc. (NOTV) implements advanced drug safety testing methods, accelerating their commercialization. Stable demand for biotechnology makes the business a defensive asset, independent of global economic crises.

NOTV (Inotiv) Earnings per share for the last twelve months history from 02/11/2024 to 06/21/2026

NOTV (Inotiv): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price Inotiv Inc|NOTV - Price Target Chart
- company stock capitalization data:
Market Capitalization Inotiv|NOTV - Real Price to Acquire Entire Company
- book value of equity indicators:
Book Price of a Share Inotiv|NOTV - Company Book Value|Market Capitalization to Book Value inotivco.com|NOTV - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Inotiv, Inc.|NOTV - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio inotivco.com|NOTV - Company Debts|Debts to Book Value Inotiv|NOTV - Company Long-Term Liabilities|Amount of Current Liabilities Inotiv|Interim Coverage Ratio inotivco.com
- net income and valuation multiples indicators:
NOTV - Net Income|Expected Profit Inotiv, Inc.|NOTV - Price to Earnings Ratio|Future Price to Earnings Multiple Inotiv Corp|NOTV - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Inotiv Corporation|NOTV - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Inotiv|NOTV - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months inotivco.com|NOTV - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Inotiv, Inc.
- revenue and sales details:
NOTV - Company Revenue|Company Revenue Forecast Inotiv Inc|NOTV - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Inotiv
Initial company analysis:NOTV, Inotiv Corp
Original product of inotivco.com

The specifics of preclinical research at Inotiv, Inc. (NOTV) ensure a steady stream of orders, making the relative YoY EPS growth over the last 12 months a key indicator of how effectively long-term R&D budgets are converted into net profit. This metric measures the rate of change in earnings per share over a rolling year, allowing investors to assess the business's resilience to debt and identify any stagnation in growth drivers in a timely manner.

Direct competitors

Net earnings per share for the last four quarters IQVIA Inc. IQV|LabCorp (LH) - Earnings per share for the last twelve months|MEDP - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ICLR|Charles River Laboratories (CRL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EVO|Net earnings per share for the last four quarters Fortrea|Earnings per share for the last twelve months Lifecore LFCR|OmniAb Inc (OABI) - Net earnings per one share for the last twelve months|CDMO: Net earnings per share for the last 12 months|CTLT - Net earnings per share (EPS TTM)|Scorpius Holdings, Inc (SCPX) - Earnings per share for the last twelve months